Health FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for neffy® (Intranasal… James Pereira May 12, 2023 <!-- Name:DistributionId Value:8837977 --> <!--… Read More...
Health ARS Pharmaceuticals Announces Availability of Briefing Documents for FDA Advisory Committee Meeting… James Pereira May 9, 2023 <!-- Name:DistributionId Value:8835136 --> <!--… Read More...
Health ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and… James Pereira Feb 24, 2023 <!-- Name:DistributionId Value:8755578 --> <!--… Read More...